Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab in refractory MuSK antibody myasthenia gravis.
Thakre M, Inshasi J, Marashi M. Thakre M, et al. Among authors: inshasi j. J Neurol. 2007 Jul;254(7):968-9. doi: 10.1007/s00415-006-0442-2. Epub 2007 Apr 30. J Neurol. 2007. PMID: 17468964 No abstract available.
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19.
Inshasi J, Alroughani R, Al-Asmi A, Alkhaboury J, Alsalti A, Boshra A, Canibano B, Deleu D, Ahmed SF, Shatila A, Thakre M. Inshasi J, et al. Neurol Ther. 2021 Dec;10(2):539-555. doi: 10.1007/s40120-021-00260-5. Epub 2021 Jun 17. Neurol Ther. 2021. PMID: 34138444 Free PMC article. Review.
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19.
Inshasi J, Alroughani R, Al-Asmi A, Alkhaboury J, Alsalti A, Boshra A, Canibano B, Deleu D, Ahmed SF, Shatila A, Thakre M. Inshasi J, et al. Neurol Ther. 2021 Jun 17:1-17. doi: 10.1007/s40120-021-00260-5. Online ahead of print. Neurol Ther. 2021. PMID: 34155473 Review.
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review.
Alroughani R, Inshasi J, Al Khawajah M, Ahmed SF, Al Malik Y, Alkhabouri J, Shatila A, Aljarallah S, Cupler EJ, Qureshi SA, Thakre M, Elhasin H, Ezzat A, Roushdy S. Alroughani R, et al. Among authors: inshasi j. Mult Scler J Exp Transl Clin. 2022 Mar 9;8(1):20552173221077185. doi: 10.1177/20552173221077185. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35284088 Free PMC article.
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study.
Inshasi J, Farouk S, Shatila A, Hassan A, Szolics M, Thakre M, Kayed D, Krieger D, Almadani A, Alsaadi T, Benedetti B, Mifsud V, Jacob A, Sayegh S, Boshra A, Alroughani R. Inshasi J, et al. Neurol Ther. 2023 Aug;12(4):1309-1318. doi: 10.1007/s40120-023-00497-2. Epub 2023 Jun 8. Neurol Ther. 2023. PMID: 37289421 Free PMC article.
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice.
Yamout B, Alroughani R, Inshasi J, Farouk S, Abdulla F, Al-Jarki NY, Alasmi A, Al Fahad S, Alkhabouri J, Al-Saffar K, Benedetti B, Canibano B, Deleu D, Hassan A, Sarathchandran P, Shatila A, Abouelnaga M, Thakre M, Szolics M, Boshra A. Yamout B, et al. Among authors: inshasi j. Neurol Ther. 2024 Oct;13(5):1321-1335. doi: 10.1007/s40120-024-00650-5. Epub 2024 Aug 3. Neurol Ther. 2024. PMID: 39097537 Free PMC article. Review.
65 results